G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,249,000 | – | 54,821 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
| CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
| Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
| Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
| Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
| Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
| Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |